244 related articles for article (PubMed ID: 23715878)
1. Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.
Lalude OO
Curr Cardiol Rep; 2013 Jul; 15(7):374. PubMed ID: 23715878
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic diseases in young women and the influence of oral contraceptives.
Lidegaard O
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
[TBL] [Abstract][Full Text] [Related]
3. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
4. Hormonal contraception, thrombosis and age.
Lidegaard Ø
Expert Opin Drug Saf; 2014 Oct; 13(10):1353-60. PubMed ID: 25227335
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic stroke and myocardial infarction with hormonal contraception.
Lidegaard Ø; Løkkegaard E; Jensen A; Skovlund CW; Keiding N
N Engl J Med; 2012 Jun; 366(24):2257-66. PubMed ID: 22693997
[TBL] [Abstract][Full Text] [Related]
6. Contraceptive choices in women with coagulation disorders.
Comp PC; Zacur HA
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
[TBL] [Abstract][Full Text] [Related]
7. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
Dragoman M; Curtis KM; Gaffield ME
Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
[TBL] [Abstract][Full Text] [Related]
8. Safety of hormonal contraceptives among women with migraine: A systematic review.
Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
[TBL] [Abstract][Full Text] [Related]
9. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.
Roach RE; Helmerhorst FM; Lijfering WM; Stijnen T; Algra A; Dekkers OM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011054. PubMed ID: 26310586
[TBL] [Abstract][Full Text] [Related]
10. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Lidegaard O; Nielsen LH; Skovlund CW; Løkkegaard E
BMJ; 2012 May; 344():e2990. PubMed ID: 22577198
[TBL] [Abstract][Full Text] [Related]
11. Hormonal contraception and risk of venous thromboembolism: national follow-up study.
Lidegaard Ø; Løkkegaard E; Svendsen AL; Agger C
BMJ; 2009 Aug; 339():b2890. PubMed ID: 19679613
[TBL] [Abstract][Full Text] [Related]
12. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
Horton LG; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
[TBL] [Abstract][Full Text] [Related]
13. Myocardial infarction and stroke in young women: what is the impact of oral contraceptives?
Lewis MA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S68-77. PubMed ID: 9753313
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular events associated with different combined oral contraceptives: a review of current data.
Hannaford P
Drug Saf; 2000 May; 22(5):361-71. PubMed ID: 10830253
[TBL] [Abstract][Full Text] [Related]
15. An epidemiologic survey of cardiovascular disease in women taking oral contraceptives.
Thorogood M; Vessey MP
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):274-81. PubMed ID: 2196799
[TBL] [Abstract][Full Text] [Related]
16. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
17. Hormonal contraception and risk of cardiovascular disease. An international perspective.
Farley TM; Collins J; Schlesselman JJ
Contraception; 1998 Mar; 57(3):211-30. PubMed ID: 9617537
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
Kelleher CC
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR; Ory H
Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
